Major market opportunities in blood group typing include advancements in PCR and NGS technologies, growing demand for ...

With rapid advancements in whole genome sequencing, Kadam noted that genetic science is moving toward even more comprehensive ...

The LATAM laboratory equipment and disposables market experienced significant growth in recent years, with a valuation of $1,759 million in 2019. Projections indicate a promising trajectory, with ...

Pregnancy loss may occur in as many as 25% of all pregnancies. Most of these losses occur in the first trimester, and about ...

Researchers at Dartmouth–Hitchcock Medical Center investigated whether OGM could detect harmful chromosomal changes in patients with a family history or risk of recurrent pregnancy loss who had ...

Revenue Guidance -- Management reiterated full-year fiscal 2025 revenue guidance of $26 million to $30 million and set Q4 ...

A 42-year-old woman gave birth to healthy twin girls after transfer of aneuploid embryos. Read how this may reshape embryo ...

The data, which is being presented at this year's AMP meeting, offers some insights into the often hidden causes of recurrent pregnancy loss.

Bionano Genomics, Inc. (NASDAQ: BNGO) Q3 2025 Earnings Call Transcript November 13, 2025 Bionano Genomics, Inc. beats ...

OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS PanelEnables ultra-low variant detection across a range of key MRD targets in AML, including very large FLT3-ITDsOxford, UK ...

(Nasdaq: SRDX) (“Surmodics” or the “Company”), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that the United States District ...

Federal judge rules divestiture plan addresses competition concerns in GTCR's acquisition of Surmodics despite FTC claims of ...